Silexion Therapeutics Corp
SLXN
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.05M
Close$
$-0.53
110.9% downside
Current Fair Value
110.9% downsideOvervalued by 110.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.05 Million |
|---|---|
| Enterprise Value | $76,271.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-89.6 |
| Beta | -0.29 |
| Outstanding Shares | 323,037 |
Return
| Return on Equity | -316.15% |
|---|---|
| Return on Assets | -19.99% |
| Return on Invested Capital | -1274.91% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | -0.21 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 5.72 |
| Debt to Equity | 1.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
$-12.90
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-13.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.13%▲ 0.54% |
|---|---|
| Total Invested | $46,692▲ 32.78% |
| Investors Holding | 7▲ 1.00% |
ESG Score
No data